User login

We offer our registered users tailored information, free online courses and exclusive content.

You have an old EXCEMED account ...

Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?

... or you lost your password?

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

New drugs for hypertension: What's in the pipeline?

New drugs for hypertension: What's in the pipeline?
  • Cardiometabolic
  • Hypertension


Resource type

Slide kit


management of hypertension
new developments
antihypertensive drugs
combination drugs
Dual action vasopeptidase inhibitors
AT2 receptor agonist
Aldosterone synthase inhibitors
Endothelin antagonists
Guanylate cyclase activators
Agents affecting arterial stiffness
clinical trials
angiotensin II receptor blockers
angiotensin converting enzyme inhibitors
Calcium channel blockers
cardiovascular events
cerebrovascular events
Target blood pressure
Target organ damage



In this practical presentation, Professor Harry Struijker-Boudier describes the different agents currently under development for the management of hypertension.

Terms of use

This is a copyrighted resource for the sole purpose of education. Resource may be used for classroom training only and must remain as is, including the branding and EXCEMED logo. It is backed by a publishing license, signed by the author.